These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6022379)

  • 21. 6-PHOSPHOGLUCONATE DEHYDROGENASE IN UTERINE CANCER DETECTION.
    HOFFMAN RL; MERRITT JW
    Am J Obstet Gynecol; 1965 Jul; 92():650-7. PubMed ID: 14308735
    [No Abstract]   [Full Text] [Related]  

  • 22. 6-phosphogluconate dehydrogenase (6PGD) activity in the cervical mucus and vaginal fluid in benign and malignant gynaecological lesions.
    Brooks PC; Muir GG
    J Obstet Gynaecol Br Commonw; 1967 Feb; 74(1):111-4. PubMed ID: 6018084
    [No Abstract]   [Full Text] [Related]  

  • 23. The source of 6-phosphogluconate dehydrogenase in vaginal fluid samples.
    Churchouse MJ; Carter GN; Bonham DG
    J Obstet Gynaecol Br Commonw; 1967 Oct; 74(5):712-22. PubMed ID: 6058534
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effectiveness of gynecologic preventive examinations--perspectives].
    Hochuli E; Rageth C
    Geburtshilfe Frauenheilkd; 1990 Jun; 50(6):483-7. PubMed ID: 2376309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of screening programmes for gynaecological cancer.
    Hakama M; Chamberlain J; Day NE; Miller AB; Prorok PC
    Br J Cancer; 1985 Oct; 52(4):669-73. PubMed ID: 4063143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of blood on the assay of 6-phosphogluconate dehydrogenase in vaginal fluid.
    Gibbs DF
    J Clin Pathol; 1968 Mar; 21(2):189-91. PubMed ID: 4235156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The alleged usefulness of 6-phosphogluconate dehydrogenase determinations in screening for uterine cancer.
    Sanner T; Bentzen H; Kolstad P; Nordbye K; Pihl A
    Acta Obstet Gynecol Scand; 1970; 49(4):371-4. PubMed ID: 5519624
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of women with abnormal cervical smears: supplement to terminology in gynaecological cytopathology.
    Evans DM; Hudson EA; Brown CL; Boddington MM; Hughes HE; Mackenzie EF
    J Clin Pathol; 1987 May; 40(5):530-1. PubMed ID: 3584504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histochemical demonstration of pentose shunt activity in smears from the uterine cervix.
    Cohen S; Way S
    Br Med J; 1966 Jan; 1(5479):88-9. PubMed ID: 5902532
    [No Abstract]   [Full Text] [Related]  

  • 30. Gynaecological and non-gynaecological abnormalities found during a two-year cancer detection survey in a cytology clinic.
    Connon AF
    Med J Aust; 1969 Feb; 1(7):329-32. PubMed ID: 5776334
    [No Abstract]   [Full Text] [Related]  

  • 31. Gynaecological mass screening in Finland.
    Timonen S
    Minerva Ginecol; 1971 Jan; 23(1):7-11. PubMed ID: 5553187
    [No Abstract]   [Full Text] [Related]  

  • 32. Screening hospital patients for uterine cervical cancer.
    Hudson E; Hewertson S; Jansz C; Gordon H
    J Clin Pathol; 1983 Jun; 36(6):611-5. PubMed ID: 6853729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. THE ACTIVITY OF 6-PHOSPHOGLUCONIC ACID DEHYDROGENASE IN VAGINAL SECRETIONS. A COMPARATIVE STUDY OF THE ACTIVITY IN WOMEN WITH AND WITHOUT GYNECOLOGICAL CANCER.
    NERDRUM HJ
    Scand J Clin Lab Invest; 1964; 16():565-9. PubMed ID: 14209218
    [No Abstract]   [Full Text] [Related]  

  • 34. Determination of 6-PGDH in the vaginal secretions of patients with carcinoma of the cervix. A new method of collection of vaginal secretions.
    Hasch E; Sorensen B; Laursen T
    Acta Obstet Gynecol Scand; 1971; 50(1):37-9. PubMed ID: 5558596
    [No Abstract]   [Full Text] [Related]  

  • 35. Are you missing gynaecological cancers at the early stage?
    Piver MS
    Mod Med Asia; 1978 Dec; 14(12):9-12. PubMed ID: 750909
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cancer prevention in postmenopausal women].
    Olsen CE; Ostergărd E
    Ugeskr Laeger; 1968 Aug; 130(33):1364. PubMed ID: 5708725
    [No Abstract]   [Full Text] [Related]  

  • 37. The early diagnosis of carcinoma of the female genital tract. I. 6-phosphogluconate dehydrogenase activity and carcinoma of the female genital tract.
    Moukhtar M; Higgins G
    J Obstet Gynaecol Br Commonw; 1965 Oct; 72(5):677-83. PubMed ID: 4284722
    [No Abstract]   [Full Text] [Related]  

  • 38. 6-phosphogluconate dehydrogenase (6PGD) activity in the vaginal fluid in benign and malignant gynaecological lesions.
    Muir GG; Canti G
    J Obstet Gynaecol Br Commonw; 1966 Aug; 73(4):611-20. PubMed ID: 5912624
    [No Abstract]   [Full Text] [Related]  

  • 39. Gynaecological screening--the benefits and pitfalls.
    Salmon YM
    Singapore Med J; 1989 Jun; 30(3):297-301. PubMed ID: 2686036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of women with abnormal cervical smears: supplement to terminology in gynaecological cytopathology.
    Slater DN
    J Clin Pathol; 1988 Jan; 41(1):114-5. PubMed ID: 3343374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.